These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 28535721)

  • 41. Generalized pustular psoriasis of pregnancy successfully treated with cyclosporine.
    Hazarika D
    Indian J Dermatol Venereol Leprol; 2009; 75(6):638. PubMed ID: 19915261
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Successful treatment of acrodermatitis continua of Hallopeau with sequential combination of calcipotriol and tacrolimus ointments.
    Brill TJ; Elshorst-Schmidt T; Valesky EM; Kaufmann R; Thaçi D
    Dermatology; 2005; 211(4):351-5. PubMed ID: 16286746
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Apremilast: A Review in Psoriasis and Psoriatic Arthritis.
    Keating GM
    Drugs; 2017 Mar; 77(4):459-472. PubMed ID: 28213862
    [TBL] [Abstract][Full Text] [Related]  

  • 44. European S3-Guideline on the systemic treatment of psoriasis vulgaris - Update Apremilast and Secukinumab - EDF in cooperation with EADV and IPC.
    Nast A; Spuls PI; van der Kraaij G; Gisondi P; Paul C; Ormerod AD; Saiag P; Smith CH; Dauden E; de Jong EM; Feist E; Jobling R; Maccarone M; Mrowietz U; Papp KA; Reich K; Rosumeck S; Talme T; Thio HB; van de Kerkhof P; Werner RN; Dressler C
    J Eur Acad Dermatol Venereol; 2017 Dec; 31(12):1951-1963. PubMed ID: 28895202
    [No Abstract]   [Full Text] [Related]  

  • 45. Apremilast and Secukinumab Combined Therapy in a Patient With Recalcitrant Plaque Psoriasis.
    Rothstein BE; McQuade B; Greb JE; Goldminz AM; Gottlieb AB
    J Drugs Dermatol; 2016 May; 15(5):648-9. PubMed ID: 27168275
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Acquired diffuse palmoplantar erythema with keratoderma in Chinese patients with pustular psoriasis: A predictor for IL36 receptor antagonist c.115+6T>C mutation?
    Hsu FL; Hsieh CY; Tsai TF
    Exp Dermatol; 2024 Mar; 33(3):e15056. PubMed ID: 38488485
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Methods report: European S3-Guideline on the systemic treatment of psoriasis vulgaris - Update Apremilast and Secukinumab - EDF in cooperation with EADV and IPC.
    Dressler C; Rosumeck S; Werner RN; van der Kraaij G; van Lumig P; Wakkee M; Spuls P; Nast A
    J Eur Acad Dermatol Venereol; 2017 Dec; 31(12):1964-1977. PubMed ID: 28944515
    [No Abstract]   [Full Text] [Related]  

  • 48. Acrodermatitis continua of Hallopeau: clinical perspectives.
    Smith MP; Ly K; Thibodeaux Q; Bhutani T; Liao W; Beck KM
    Psoriasis (Auckl); 2019; 9():65-72. PubMed ID: 31497529
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Acrodermatitis continua of Hallopeau is a clinical phenotype of DITRA: evidence that it is a variant of pustular psoriasis.
    Abbas O; Itani S; Ghosn S; Kibbi AG; Fidawi G; Farooq M; Shimomura Y; Kurban M
    Dermatology; 2013; 226(1):28-31. PubMed ID: 23428889
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Gastrointestinal bleeding with severe mucosal involvement in a patient with generalized pustular psoriasis without IL36RN mutation.
    Komatsuda S; Kamata M; Chijiwa C; Namiki K; Fukaya S; Hayashi K; Fukuyasu A; Tanaka T; Ishikawa T; Ohnishi T; Abe K; Yamamoto T; Aozasa N; Sugiura K; Tada Y
    J Dermatol; 2019 Jan; 46(1):73-75. PubMed ID: 30474867
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pneumocystis jirovecii pneumonia in a patient with pustular psoriasis with an IL-36RN deficiency treated with infliximab: Case report and review of the literature.
    Podlipnik S; de la Mora L; Alsina M; Mascaró JM
    Australas J Dermatol; 2017 May; 58(2):e44-e47. PubMed ID: 27170513
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Real-World Experience With Apremilast in Treating Psoriasis.
    Mayba JN; Gooderham MJ
    J Cutan Med Surg; 2017; 21(2):145-151. PubMed ID: 27846617
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Systemic Treatment of Recalcitrant Pediatric Psoriasis: A Case Series and Literature Review.
    Garber C; Creighton-Smith M; Sorensen EP; Dumont N; Gottlieb AB
    J Drugs Dermatol; 2015 Aug; 14(8):881-6. PubMed ID: 26267734
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Successful use of infliximab as first line treatment for severe childhood generalized pustular psoriasis.
    Tsang V; Dvorakova V; Enright F; Murphy M; Gleeson C
    J Eur Acad Dermatol Venereol; 2016 Nov; 30(11):e117-e119. PubMed ID: 26403378
    [No Abstract]   [Full Text] [Related]  

  • 55. Successful treatment of juvenile generalized pustular psoriasis with infliximab therapy: two case reports.
    Lu J; Li Y; Yu N; Chen F; Ding Y; Yi X
    J Int Med Res; 2020 Mar; 48(3):300060520912091. PubMed ID: 32216562
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Successful treatment of hand and foot psoriasis with infliximab.
    Di Lernia V; Guareschi E
    Dermatol Online J; 2010 Jul; 16(7):8. PubMed ID: 20673536
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Apremilast in psoriasis - a prospective real-world study.
    Vujic I; Herman R; Sanlorenzo M; Posch C; Monshi B; Rappersberger K; Richter L
    J Eur Acad Dermatol Venereol; 2018 Feb; 32(2):254-259. PubMed ID: 28925560
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pustular psoriasis in childhood and adolescence: a 20-year single-center experience.
    Popadic S; Nikolic M
    Pediatr Dermatol; 2014; 31(5):575-9. PubMed ID: 24602000
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clinical experience with systemic cyclosporine A treatment in severe childhood psoriasis.
    Bulbul Baskan E; Yazici S; Tunali S; Saricaoglu H
    J Dermatolog Treat; 2016 Aug; 27(4):328-31. PubMed ID: 26651208
    [TBL] [Abstract][Full Text] [Related]  

  • 60. An update on generalized pustular psoriasis.
    Gooderham MJ; Van Voorhees AS; Lebwohl MG
    Expert Rev Clin Immunol; 2019 Sep; 15(9):907-919. PubMed ID: 31486687
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.